Fermenta Biotech Gains 7.07%: Valuation Shift and Q2 Margins Underline Volatile Week
2026-11-08 11:01:06Key Events This Week 2 Nov: Valuation shifts to attractive amid market volatility 6 Nov: Q2 FY27 results reveal margin pressures despite modest revenue growth 5 Nov: Sharp 5.09% price decline on heavy volume 6 Nov: Week closes at Rs.447.05 (+7.07%) Week OpenRs.417.55 Week CloseRs.447.05<d...
Read More
Fermenta Biotech Ltd is Rated Sell
2026-11-05 10:11:34Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Fermenta Biotech Ltd is Rated Sell by MarketsMOJO
2026-10-25 10:10:30Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 October 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.
Read MoreFermenta Biotech Declines 5.72% Despite Sector Valuation Reset and Mixed Technical Signals
2026-10-18 12:00:07Key Events This Week Oct 12: Valuation shift to fair grade amid sector challenges Oct 13-14: Price volatility with sharp declines Oct 16: Mixed technical signals amid mild price recovery Week Close: Rs.487.90 (-5.72%) vs Sensex +1.91% Week OpenRs.519.40 Week CloseRs.487.90<div class="stat...
Read More
Fermenta Biotech Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-10-16 08:01:08Fermenta Biotech Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of mid-October 2026. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s technical indicators present a complex picture, with some metrics signalling caution while others suggest potential for recovery. This article analyses the latest price movements, technical indicator readings, and broader market context to provide a comprehensive view for investors.
Read More
Fermenta Biotech Ltd is Rated Sell
2026-10-14 10:10:05Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 6 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Fermenta Biotech Ltd: Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges
2026-10-12 08:00:12Fermenta Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair price territory, as reflected in its latest price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This adjustment comes amid robust stock performance that has significantly outpaced the broader market indices over multiple time horizons.
Read MoreFermenta Biotech Ltd Falls 6.87%: Key Events and Market Reaction This Week
2026-10-11 11:00:34Key Events This Week 05 Oct: Week opens at Rs.555.70 06 Oct: New 52-week high at Rs.580.5 and all-time high close at Rs.572.15 08 Oct: Sharp decline of 5.04% to Rs.537.85 09 Oct: Week closes at Rs.517.50, down 3.78% on the day Week OpenRs.555.70 Week CloseRs.517.50<div class="stat-change ...
Read More
Broad-Based Technical Strength Lifts Fermenta Biotech Ltd to 52-Week High of Rs 580.5
2026-10-06 12:05:11Surging past its previous peak, Fermenta Biotech Ltd touched a fresh 52-week high of Rs 580.5 on 6 Oct 2026, marking a remarkable rally of 75.21% over the past year. This milestone comes amid a sustained six-day winning streak that has propelled the stock 20.4% higher, underscoring the strong momentum driving this micro-cap pharmaceutical player.
Read MoreAnnouncement under Regulation 30 (LODR)-Investor Presentation
06-Nov-2026 | Source : BSEIntimation regarding earnings presentation- Q2/H1FY27.
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Nov-2026 | Source : BSENewspaper publication regarding unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30 2026.
Intimation Regarding The BoardS Decision To Close The CompanyS Wholly-Owned Subsidiary - Fermenta Biotech (UK) Limited.
05-Nov-2026 | Source : BSEIntimation regarding the Boards decision to close the Companys wholly-owned subsidiary - Fermenta Biotech (UK) Limited.
Corporate Actions
No Upcoming Board Meetings
Fermenta Biotech Ltd has declared 75% dividend, ex-date: 05 Aug 26
Fermenta Biotech Ltd has announced 5:5 stock split, ex-date: 08 Aug 18
Fermenta Biotech Ltd has announced 2:1 bonus issue, ex-date: 13 Feb 20
No Rights history available